ClinicalTrials.Veeva

Menu

Comparative Analysis of PCM With ROTEM in the Measurement of Viscoelastic Coagulation Parameters

E

Entegrion

Status

Unknown

Conditions

Hemostasis Monitoring

Treatments

Device: PCM and ROTEM

Study type

Observational

Funder types

Industry

Identifiers

NCT03679286
PCM-002

Details and patient eligibility

About

To determine if PMC viscoelastic coagulation parameters correlate with those generated by a marketed device in adult patients who require hemostasis monitoring or who are at risk of bleeding or thrombotic indications

Full description

The primary aim of this study is a performance evaluation of the PCM coagulation monitor in comparison to the ROTEM thromboelastometry system.

To include a measurement of the entire range of the test system, subjects with a medical management need that requires the measurement of their hemostasis status (such as PT/PTT, INR) or are at risk for being hypo-coagulable or hyper-coagulable will be included in this study.

Enrollment

120 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18 years or older
  • In opinion of investigator, absence of anything that precludes subject from being good study candidate
  • Informed consent
  • Order for measurement of hemostasis status of patients who are at risk for being hyper-coagulable or hypo-coagulable due to clinical diagnosis or medical need

Exclusion criteria

  • Previous enrollment in study
  • Incarcerated
  • Heparin infusion in prior 24 hours

Trial design

120 participants in 1 patient group

All subjects
Description:
No intervention
Treatment:
Device: PCM and ROTEM

Trial contacts and locations

3

Loading...

Central trial contact

Chris Lindsell, PhD; Entegrion

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems